Financial Gravity Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2
Closed -$200 1216
2023
Q4
$200 Buy
+2
New +$207 ﹤0.01% 1043
2021
Q3
$131K Buy
25
+1
+4% +$131 0.06% 279
2021
Q2
$137K Buy
+24
New +$3.29K 0.05% 265
2020
Q4
$0 Buy
+2
New +$189 ﹤0.01% 510
2019
Q4
$112K Buy
+172
New +$18.3K 0.08% 276
2018
Q3
Sell
-5
Closed 1418
2018
Q2
$0 Sell
5
-661
-99% -$45K ﹤0.01% 1433
2018
Q1
$44K Buy
+666
New +$39.8K 0.05% 343

Other funds holding CNMD

Financial Gravity Asset Management's CNMD Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2 shares — an estimated $200 sold.

Financial Gravity Asset Management first reported a position in CNMD in Q1 2018 and held it in 7 quarters. The position peaked at $137K in Q2 2021. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 2 CONMED shares in Q1 2024, an estimated $200.
  • Financial Gravity Asset Management first reported a position in CONMED in Q1 2018 and held it in 7 quarters.
  • Financial Gravity Asset Management's CONMED position peaked at $137K in Q2 2021.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.